Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Long intergenic non-protein coding RNA 1608 (LINC01608) is a member of the long intergenic non-coding RNA family. LincRNAs are non-protein coding RNAs longer than 200 nucleotides that do not overlap protein-coding genes. These molecules commonly regulate gene expression at multiple levels—epigenetic, transcriptional, and post-transcriptional—through interactions with DNA, RNA, or proteins. LincRNAs can influence chromatin structure and gene activity, serving as scaffolds, guides, or molecular "sponges" for other RNAs, such as microRNAs. While lincRNAs, in general, have been associated with numerous cellular processes and some are linked to disease states, there is no specific published function, disease association, or drug interaction assigned to LINC01608 as of the most recent data.
Not applicable for drugs, as there are no known drugs targeting LINC01608
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Long intergenic non-protein coding RNA 1608 (LINC01608).